About One-Third of Cancer Survivors Used Cannabis, and Most Told Their Healthcare Provider
Among 719 cancer survivors surveyed, roughly one-third reported current cannabis use, with most discussing it with a healthcare provider and expressing interest in receiving more cannabis information.
Quick Facts
What This Study Found
About one-third of 719 cancer survivors reported current cannabis use. Cannabis use varied across the cancer care continuum. Most cannabis-using survivors discussed their use with a healthcare provider and reported interest in receiving more information about cannabis.
Key Numbers
719 participants; most currently undergoing treatment; approximately one-third current cannabis use; most disclosed to healthcare providers; most wanted more cannabis information; use varied across cancer care stages
How They Did This
Cross-sectional online survey distributed through online health communities, collecting responses from 719 cancer survivors (most currently undergoing treatment) about cannabis behaviors, disclosure, and information needs.
Why This Research Matters
With roughly a third of cancer survivors using cannabis, healthcare providers need to be prepared for these conversations. The finding that most cannabis-using patients are willing to discuss and want more information suggests an opportunity for better clinical guidance.
The Bigger Picture
Unlike many other populations where cannabis use goes undisclosed, cancer survivors appear relatively open about their cannabis use with providers. This openness creates an opportunity for evidence-based guidance that is currently lacking in most oncology settings.
What This Study Doesn't Tell Us
Online recruitment through health communities may oversample engaged patients, self-reported cannabis use, cross-sectional design, no information on cancer types or stages, participants may be more comfortable with cannabis than the general cancer population
Questions This Raises
- ?What specific cannabis information do cancer survivors want most?
- ?Are oncologists prepared to provide evidence-based cannabis guidance?
- ?Does cannabis use vary by cancer type, stage, or treatment phase?
Trust & Context
- Key Stat:
- About one-third of cancer survivors used cannabis, and most disclosed use to providers
- Evidence Grade:
- Moderate-sized survey but online recruitment may not be representative; provides useful descriptive data on disclosure patterns
- Study Age:
- Published 2025
- Original Title:
- Cannabis Use and Disclosure in the Oncology Setting: A Cross-Sectional Survey Exploring Information Needs Among Cancer Survivors.
- Published In:
- Clinical journal of oncology nursing, 29(2), 157-164 (2025)
- Authors:
- Camp, Lindsey Nicole, Babicheva, Viktoriya, Conahan, Catherine, Hayes, Sara, Sherburne Hawkins, Summer
- Database ID:
- RTHC-06149
Evidence Hierarchy
A snapshot of a population at one point in time.
What do these levels mean? →Frequently Asked Questions
How many cancer patients use cannabis?
In this survey of 719 cancer survivors, about one-third reported current cannabis use. Use patterns varied depending on where patients were in their cancer care journey.
Do cancer patients tell their doctors about cannabis use?
Most cannabis-using cancer survivors in this study discussed their use with a healthcare provider and expressed interest in receiving more information about cannabis.
Read More on RethinkTHC
- CBD-oil-quality-guide
- anxiety-medication-after-quitting-weed
- cannabis-chemotherapy-nausea
- cannabis-chronic-pain-research
- cannabis-epilepsy-CBD-Epidiolex
- cbd-anxiety-research-evidence
- cbd-for-weed-withdrawal
- cbd-vs-thc-difference
- medical-benefits-of-cannabis
- quitting-weed-before-surgery
- quitting-weed-medication-interactions
- quitting-weed-pregnancy
- quitting-weed-pregnant
- seniors-older-adults-cannabis-risks-medications
- weed-breastfeeding-THC-breast-milk
Cite This Study
https://rethinkthc.com/research/RTHC-06149APA
Camp, Lindsey Nicole; Babicheva, Viktoriya; Conahan, Catherine; Hayes, Sara; Sherburne Hawkins, Summer. (2025). Cannabis Use and Disclosure in the Oncology Setting: A Cross-Sectional Survey Exploring Information Needs Among Cancer Survivors.. Clinical journal of oncology nursing, 29(2), 157-164. https://doi.org/10.1188/25.CJON.157-164
MLA
Camp, Lindsey Nicole, et al. "Cannabis Use and Disclosure in the Oncology Setting: A Cross-Sectional Survey Exploring Information Needs Among Cancer Survivors.." Clinical journal of oncology nursing, 2025. https://doi.org/10.1188/25.CJON.157-164
RethinkTHC
RethinkTHC Research Database. "Cannabis Use and Disclosure in the Oncology Setting: A Cross..." RTHC-06149. Retrieved from https://rethinkthc.com/research/camp-2025-cannabis-use-and-disclosure
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.